Provided by Tiger Trade Technology Pte. Ltd.

Hutchison China Meditech

12.63
+0.07000.56%
Post-market: 12.630.00000.00%16:10 EDT
Volume:64.40K
Turnover:814.41K
Market Cap:2.20B
PE:125.11
High:12.70
Open:12.56
Low:12.55
Close:12.56
52wk High:18.30
52wk Low:9.77
Shares:174.43M
Float Shares:104.00M
Volume Ratio:0.66
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1010
EPS(LYR):2.60
ROE:1.46%
ROA:-1.24%
PB:1.75
PE(LYR):4.86

Loading ...

Paychex Named One of America's Most Trustworthy Companies by Newsweek

GlobeNewswire
·
Jun 22

Edgewise Therapeutics Reports Improvements In Heart Drug Trial

Benzinga
·
Jun 17

Edgewise Therapeutics Advances EDG-7500 to Phase 3 Following 'Positive' HCM Data

MT Newswires Live
·
Jun 16

Paychex Recognized as a Top WorkTech Company by TIME

GlobeNewswire
·
Jun 15

Black Titan Reports January 2026 Results and Outlines HCM and Digital Asset Strategies

TIPRANKS
·
Jun 13

Hutchmed Unveils Phase III Data for Sovleplenib in wAIHA at 2026 EHA Congress

Stock News
·
Jun 12

Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions

GlobeNewswire
·
Jun 03

Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in Germany

GlobeNewswire
·
Jun 01

Morgan Stanley Reaffirms Their Hold Rating on HUTCHMED (China) (HCM)

TIPRANKS
·
May 30

Hutchmed upgraded to Equal Weight from Underweight at Morgan Stanley

TIPRANKS
·
May 29

Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

GlobeNewswire
·
May 28

UBS Reaffirms Their Buy Rating on HUTCHMED (China) (HCM)

TIPRANKS
·
May 23

Analysts’ Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM), PepGen Inc. (PEPG) and Glaukos (GKOS)

TIPRANKS
·
May 22

HUTCHMED Hits Annual Low: When Will the Turning Point Arrive?

Stock News
·
May 22

HUTCHMED to Unveil Data at ASCO 2026 Annual Meeting

Stock News
·
May 22

Hutchmed, Innovent Biologics Win NMPA Approval for Renal Cancer Therapy

MT Newswires Live
·
May 21

Hutchmed, Innovent jointly announce NMPA approval for Elunate/Tyvyt combination

TIPRANKS
·
May 21

Newmark Security Accelerates HCM-Focused Strategy as Revenue and North American Sales Surge

TIPRANKS
·
May 21

Press Release: Poxel Reports First Quarter 2026 Revenue and Provides a Business Update

Dow Jones
·
May 20

Positive Interim Data from Cohorts 1 and 2 of Tenaya’s RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC

GlobeNewswire
·
May 15